Arcturus Therapeutics In Deal With Johnson & Johnson Innovation
socalTECH
JUNE 11, 2015
San Diego-based RNA therapeutics developer Arcturus Therapeutics announced this morning that it is in a strategic collaboration deal, with Johnson & Johnson Innovation. Plus, Janssen will assume responsibility for development and commercialization costs associated with the new program. READ MORE>>.
Let's personalize your content